IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Gilead Sciences, Inc.

Q4 2025 Holdings

Filed 2026-02-12 | 6 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$748.9M31,424,76038.7%
Galapagos NV(GLPG)SPON ADR36315X101$550.6M16,707,47728.4%
Arcellx Inc(ACLX)COMMON STOCK03940C100$438.2M6,720,80322.6%
Assembly Biosciences Inc(ASMB)COM NEW045396207$153.2M4,505,3917.9%
Kyverna Therapeutics Inc(KYTX)COM501976104$38.8M4,126,1192.0%
Xilio Therapeutics Inc(XLO)COM98422T100$5.8M9,105,4510.3%